Treatment with a fungus called Ophiocordyceps sinensis eased disease signs and improved survival in a rat model of pulmonary…
Articles by Marisa Wexler, MS
Treatment with the investigational medication levosimendan was found to improve exercise tolerance, and some parameters related to heart function, in…
Experts will discuss how the COVID-19 pandemic has affected people living with pulmonary hypertension and other rare respiratory…
Acute pulmonary hypertension (aPH) is frequent and linked with a higher risk of mortality in people who are severely ill…
People with pulmonary hypertension are less likely to be referred to exercise therapy if they are of lower socioeconomic…
PhaseBio Pharmaceuticals‘s investigational therapy pemziviptadil (PB1046) showed a good safety…
The European Commission has granted orphan drug designation to sotatercept for the treatment of people with pulmonary arterial…
Enrollment is resuming for the VIP clinical trial, which is evaluating PhaseBio Pharmaceuticals‘ investigational therapy pemziviptadil (PB1046) in people…
Beyond Air filed an application with the U.S. Food and Drug Administration (FDA) requesting approval of its LungFit…
Mayo Clinic and Vocalis Health announced a collaboration to research and develop new voice-based tools for screening, detecting, and…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
Treatment with Tyvaso (inhaled treprostinil) can improve lung function in people with pulmonary hypertension associated with…